Collegium Pharmaceutical
COLL
COLL
227 hedge funds and large institutions have $1.54B invested in Collegium Pharmaceutical in 2024 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 78 increasing their positions, 78 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
18% more funds holding
Funds holding: 193 → 227 (+34)
0.53% more ownership
Funds ownership: 123.34% → 123.87% (+0.53%)
0% more repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 78
Holders
227
Holding in Top 10
2
Calls
$3.33M
Puts
$601K
Top Buyers
| 1 | +$37.6M | |
| 2 | +$16M | |
| 3 | +$9.66M | |
| 4 |
Man Group
London,
United Kingdom
|
+$7.96M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$7.38M |
Top Sellers
| 1 | -$45.3M | |
| 2 | -$35.9M | |
| 3 | -$10.7M | |
| 4 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
-$10.6M |
| 5 |
Millennium Management
New York
|
-$9.72M |